Target intelligence / Profile preview

SET pseudogene 3 (SETP3)

Target
SETP3
Molecular classification
Other (pseudogene)
01

Overview

SET pseudogene 3 (SETP3) is a processed pseudogene, meaning it is a DNA sequence derived from a functional ancestral gene (likely related to the SET gene) that has lost its protein-coding ability due to disabling mutations or lack of core promoters[1][2][4][5]. Pseudogenes like SETP3 are generally considered nonfunctional remnants; while some pseudogenes have been shown to play regulatory roles in gene expression at the level of RNA, there is no evidence that SETP3 does so[2][3][4]. Pseudogenes can complicate molecular genetic studies due to their sequence similarity to functional genes, but they are not direct therapeutic targets[4]. There are no known drugs, clinical biomarkers, safety concerns, or validated disease associations tied to SETP3. In summary, SET pseudogene 3 (SETP3) is not a valid therapeutic or biological target and should be excluded from most target-based analyses[1][2][4].

Other names
SETP13
02

Biological functions

Other (no known coding function; general roles possible for some pseudogenes in gene regulation)
03

Disease associations

Other (pseudogenes rarely, and only via RNA-based regulatory mechanisms, have disease associations; none specifically known for SETP3)

Beyond the preview

Go deeper on SET pseudogene 3 (SETP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SET pseudogene 3 (SETP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call